# FDA Inspection 1018004 - Summit Biosciences Inc. - June 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/c0f4cc8b-fd56-4d6f-8d17-f9e0da7f4f8a
Source feed: FDA_Inspections

> FDA Inspection 1018004 for Summit Biosciences Inc. on June 23, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018004
- Company Name: Summit Biosciences Inc.
- Inspection Date: 2017-06-23
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261583 - 2025-02-21](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/fbf78c84-7d7e-4694-9f67-ee101159342d)
- [FDA Inspection 1218227 - 2023-09-14](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/4dfd068f-13de-4321-897b-877c72d3592b)
- [FDA Inspection 1121348 - 2020-02-04](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/19d10378-051a-47ff-b8a8-b4e78e1d0333)
- [FDA Inspection 933643 - 2015-06-18](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/57f4ace6-9ae3-4f29-8fe5-f8e2e4db37e2)
- [FDA Inspection 868633 - 2014-02-28](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/38015c8a-d915-445e-93fb-f6c08c9fe811)

Company: https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c